<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2020-08-01</periodOfReport>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001463361</issuerCik>
        <issuerName>Unity Biotechnology, Inc.</issuerName>
        <issuerTradingSymbol>UBX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001727640</rptOwnerCik>
            <rptOwnerName>Sullivan Lynne Marie</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O UNITY BIOTECHNOLOGY, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>285 EAST GRAND AVENUE</rptOwnerStreet2>
            <rptOwnerCity>SOUTH SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94080</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>See  Remarks</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <footnotes></footnotes>

    <remarks>Interim Chief Financial Officer</remarks>

    <ownerSignature>
        <signatureName>/s/ Tamara L. Tompkins, as Attorney-in-Fact for Lynne Sullivan</signatureName>
        <signatureDate>2020-08-04</signatureDate>
    </ownerSignature>
</ownershipDocument>
